We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Evotec Achieves Clinical Development Milestone from Bayer

News   Aug 04, 2016

 
Evotec Achieves Clinical Development Milestone from Bayer
 
 
 

RELATED ARTICLES

Accelerating Chemical Synthesis With "Turbo Chip"

News

Researchers have developed a process that facilitates and accelerates chemical synthesis and biological screening by combining all steps on a chip.

READ MORE

New Libido Drug Vyleesi Approved to Treat Hypoactive Sexual Desire in Women

News

The U.S. Food and Drug Administration today approved Vyleesi (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.

READ MORE

Cannabidiol Holds Promise as Powerful Antibiotic

News

New research has found that cannabidiol is active against Gram-positive bacteria, including those responsible for many serious infections, with potency similar to that of established antibiotics such as vancomycin or daptomycin.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE